Beacon Biosignals is an innovative health technology firm dedicated to bridging the gap between clinical diagnostics and at-home monitoring. By marrying high-fidelity EEG data with proprietary AI-driven analytics, the company provides researchers and pharmaceutical partners with the tools necessary to accelerate the development of next-generation therapies for brain disorders.
The firm operates with a modern mindset, championing asynchronous work practices that empower team members across their offices in Boston, New York, and Paris to contribute effectively from anywhere. For mission-driven professionals, Beacon offers the unique opportunity to merge data science, neurology, and patient-centered product design in a fast-paced, high-impact environment.